Drug Shortage Report for ZANTAC

Last updated on 2020-02-27 History
Report ID 2745
Drug Identification Number 02212331
Brand name ZANTAC
Common or Proper name Ranitidine tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2016-10-04
Estimated end date
Actual end date 2017-09-14
Shortage status Resolved
Updated date 2020-02-27
Company comments This product has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-14 English Compare
v2 2017-03-14 French Compare
v3 2017-03-17 English Compare
v4 2017-03-17 French Compare
v5 2017-09-18 English Compare
v6 2017-09-18 French Compare
v7 2020-02-27 English Compare
v8 2020-02-27 French Compare

Showing 1 to 8 of 8